1. IgA antibody response of swine to foot-and-mouth disease virus infection and vaccination.
- Author
-
Pacheco JM, Butler JE, Jew J, Ferman GS, Zhu J, and Golde WT
- Subjects
- Animals, Enzyme-Linked Immunosorbent Assay methods, Immunoglobulin G blood, Immunoglobulin M blood, Saliva immunology, Vaccines, Inactivated immunology, Antibodies, Viral blood, Foot-and-Mouth Disease Virus immunology, Immunoglobulin A blood, Swine Diseases immunology, Viral Vaccines immunology
- Abstract
Foot-and-mouth disease virus (FMDV) continues to be a significant economic problem worldwide. Control of the disease involves the use of killed-virus vaccines, a control measure developed decades ago. After natural infection, the primary site of replication of FMDV is the pharyngeal area, suggesting that a mucosal immune response is the most effective. Humoral immunity to killed-virus vaccination induces antibodies that can prevent the clinical disease but not local infection. Determining whether infection or vaccination stimulates IgA-mediated local immunity depends on the method of analysis. Different assays have been described to analyze the quality of antibody responses of cattle and swine to FMDV, including indirect double-antibody sandwich enzyme-linked immunosorbent assay (IDAS-ELISA) and antibody capture assay-ELISA (ACA-ELISA). We tested these assays on swine and show that vaccinated animals had FMDV-specific IgM and IgG but no IgA in either serum or saliva. After the infection, both assays detected FMDV-specific IgM, IgG, and IgA in serum. Notably, serum IgA was more readily detected using the ACA-ELISA, whereas IgA was not detected in saliva with this assay. FMDV-specific IgA antibodies were detected in saliva samples using the IDAS-ELISA. These data show that parenterally administered, killed-virus vaccine does not induce a mucosal antibody response to FMDV and illuminates limitations and appropriate applications of the two ELISAs used to measure FMDV-specific responses. Further, the presence of the IgA antivirus in serum correlates with the presence of such antibodies in saliva.
- Published
- 2010
- Full Text
- View/download PDF